🇺🇸 FDA
Patent

US 7183388

Anti-MUC-1 single chain antibodies for tumor targeting

granted A61KA61K2039/505

Quick answer

US patent 7183388 (Anti-MUC-1 single chain antibodies for tumor targeting) held by The Regents of the University of California expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2039/505